This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liaw, L. Articles by Schwartz, S. M. Search for Related Content PubMed PubMed Citation Articles by Liaw, L. Articles by Schwartz, S. M.

American Journal of Pathology, Vol 143, 937-948, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Microtubule disruption stimulates DNA synthesis in bovine endothelial cells and potentiates cellular response to basic fibroblast growth factor

L Liaw and SM Schwartz
Department of Pathology, University of Washington, Seattle 98195.

Cultured endothelial cells characteristically form a monolayer and become quiescent at saturation density. This study shows that microtubule destabilization in confluent cultures of bovine aortic endothelial cells stimulates fibroblast growth factor 2 (FGF-2, bFGF)- dependent DNA synthesis. Twenty-four hours after addition of the microtubule-disrupting drug colchicine, tritiated thymidine incorporation increases up to fivefold when compared to control cultures. Significant stimulation is seen with doses from 0.05 to 1.0 microgram/ml. The effect of colchicine is quantitatively similar to stimulation of the same cultures with 5 ng/ml FGF-2. Furthermore, the stimulation of DNA synthesis by colchicine can be completely blocked by the addition of a neutralizing antibody to FGF-2. This suggests that colchicine may stimulate bovine aortic endothelial cells by modulating endogenous FGF-2/receptor interactions or that colchicine acts by a different mechanism that requires the growth factor for mitogenicity. The combined effects of colchicine and FGF-2 are more than additive, which supports the idea that microtubule disruption may facilitate cellular response to FGF-2. Cytochalasin B, preventing actin polymerization, inhibits the mitogenic response to FGF-2 but not the response to colchicine. These results are best interpreted as evidence that colchicine stimulates endothelial cell DNA synthesis by a pathway that requires endogenous FGF-2 and may be facilitating cellular responsiveness to the growth factor by disrupting the monolayer via the cytoskeleton.

This article has been cited by other articles:

				P. U. Magnusson, R. Ronca, P. Dell'Era, P. Carlstedt, L. Jakobsson, J. Partanen, A. Dimberg, and L. Claesson-Welsh Fibroblast Growth Factor Receptor-1 Expression Is Required for Hematopoietic but not Endothelial Cell Development Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 944 - 949. [Abstract] [Full Text] [PDF]

				J. Park, L. M. Kamendulis, M. A. Friedman, and J. E. Klaunig Acrylamide-Induced Cellular Transformation Toxicol. Sci., February 1, 2002; 65(2): 177 - 183. [Abstract] [Full Text] [PDF]

				M. Thornton, L. Barkley, J. C. Mason, and S. Shaunak Anti-Kaposi's Sarcoma and Antiangiogenic Activities of Sulfated Dextrins Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2528 - 2533. [Abstract] [Full Text]

				V. Lindner and M. A. Reidy Expression of VEGF Receptors in Arteries After Endothelial Injury and Lack of Increased Endothelial Regrowth in Response to VEGF Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1399 - 1405. [Abstract] [Full Text]